Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study

Por Shiffman, Dov, Chasman, Daniel I., Ballantyne, Christie M., Nambi, Vijay, Devlin, James J., Boerwinkle, Eric
Publicado no Thromb Haemost (2009)

Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis

Por Shiffman, Dov, Perez, Marco V., Bare, Lance A., Louie, Judy Z., Arellano, Andre R., Devlin, James J.
Publicado no BMC Cardiovasc Disord (2015)

Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma

Por Li, Yonghong, Bare, Lance A., Bender, Richard A., Sninsky, John J., Wilson, Leslie S., Devlin, James J., Waldman, Frederic M.
Publicado no Mol Diagn Ther (2015)

Use of low density lipoprotein particle number levels as an aid in statin treatment decisions for intermediate risk patients: a cost-effectiveness analysis

Por Shiffman, Dov, Arellano, Andre R., Caulfield, Michael P., Louie, Judy Z., Bare, Lance A., Devlin, James J., Melander, Olle
Publicado no BMC Cardiovasc Disord (2016)

Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history

Por Tada, Hayato, Melander, Olle, Louie, Judy Z., Catanese, Joseph J., Rowland, Charles M., Devlin, James J., Kathiresan, Sekar, Shiffman, Dov
Publicado no Eur Heart J (2016)

Single Nucleotide Polymorphisms Associated with Coronary Heart Disease Predict Incident Ischemic Stroke in the Atherosclerosis Risk in Communities Study

Por Morrison, Alanna C., Bare, Lance A., Luke, May M., Pankow, James S., Mosley, Thomas H., Devlin, James J., Willerson, James T., Boerwinkle, Eric
Publicado em 2008

The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study

Por Shiffman, Dov, O'Meara, Ellen S, Rowland, Charles M, Louie, Judy Z, Cushman, Mary, Tracy, Russell P, Devlin, James J, Psaty, Bruce M
Publicado em 2011

A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND

Por Shiffman, Dov, Pare, Guillaume, Oberbauer, Rainer, Louie, Judy Z., Rowland, Charles M., Devlin, James J., Mann, Johannes F., McQueen, Matthew J.
Publicado em 2014

Analysis of 17,576 Potentially Functional SNPs in Three Case–Control Studies of Myocardial Infarction

Por Shiffman, Dov, Kane, John P., Louie, Judy Z., Arellano, Andre R., Ross, David A., Catanese, Joseph J., Malloy, Mary J., Ellis, Stephen G., Devlin, James J.
Publicado em 2008

Polymorphisms Associated with Both Noncardioembolic Stroke and Coronary Heart Disease: Vienna Stroke Registry

Por Luke, May M., Lalouschek, Wolfgang, Rowland, Charles M., Catanese, Joseph J., Bolonick, Joel I., Bui, Nam D., Greisenegger, Stefan, Endler, Georg, Devlin, James J., Mannhalter, Christine
Publicado em 2009

Investigation of KIF6 Trp719Arg in a Case-Control Study of Myocardial Infarction: A Costa Rican Population

Por Bare, Lance A., Ruiz-Narvaéz, Edward A., Tong, Carmen H., Arellano, Andre R., Rowland, Charles M., Catanese, Joseph J., Sacks, Frank M., Devlin, James J., Campos, Hannia
Publicado em 2010

A Twelve-SNP Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke

Por Tada, Hayato, Shiffman, Dov, Smith, J. Gustav, Sjögren, Marketa, Lubitz, Steven A., Ellinor, Patrick T., Louie, Judy Z., Catanese, Joseph J., Engström, Gunnar, Devlin, James J., Kathiresan, Sekar, Melander, Olle
Publicado no Stroke (2014)

Polymorphism in the Apolipoprotein(a) Gene, Plasma Lipoprotein(a), Cardiovascular Disease, and Low-dose Aspirin Therapy

Por Chasman, Daniel I., Shiffman, Dov, Zee, Robert Y. L., Louie, Judy Z., Luke, May M., Rowland, Charles M., Catanese, Joseph J., Buring, Julie E, Devlin, James J., Ridker, Paul M
Publicado em 2008

Genetic variants in the KIF6 region and coronary event reduction from statin therapy

Por Li, Yonghong, Sabatine, Marc S., Tong, Carmen H., Ford, Ian, Kirchgessner, Todd G., Packard, Christopher J., Robertson, Michele, Rowland, Charles M., Bare, Lance A., Shepherd, James, Devlin, James J., Iakoubova, Olga A.
Publicado em 2010

Gene Variants Associated With Ischemic Stroke: The Cardiovascular Health Study

Por Luke, May M., O’Meara, Ellen S., Rowland, Charles M., Shiffman, Dov, Bare, Lance A., Arellano, Andre R., Longstreth, W.T., Lumley, Thomas, Rice, Kenneth, Tracy, Russell P., Devlin, James J., Psaty, Bruce M.
Publicado em 2008

Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses

Por Trompet, Stella, de Craen, Anton JM, Postmus, Iris, Ford, Ian, Sattar, Naveed, Caslake, Muriel, Stott, David J, Buckley, Brendan M, Sacks, Frank, Devlin, James J, Slagboom, P Eline, Westendorp, Rudi GJ, Jukema, J Wouter
Publicado em 2011

F9 Malmö, factor IX and deep vein thrombosis

Por Bezemer, Irene D., Arellano, Andre R., Tong, Carmen H., Rowland, Charles M., Ireland, Helen A., Bauer, Kenneth A., Catanese, Joseph, Reitsma, Pieter H., Doggen, Carine J.M., Devlin, James J., Rosendaal, Frits R., Bare, Lance A.
Publicado em 2009

Association of Gene Variants with Incident Myocardial Infarction in the Cardiovascular Health Study

Por Shiffman, Dov, O’Meara, Ellen S, Bare, Lance A, Rowland, Charles M, Louie, Judy Z, Arellano, Andre R, Lumley, Thomas, Rice, Kenneth, Iakoubova, Olga, Luke, May M, Young, Bradford A, Malloy, Mary J, Kane, John P, Ellis, Stephen G, Tracy, Russell P, Devlin, James J, Psaty, Bruce M
Publicado em 2007

Identification of Four Gene Variants Associated with Myocardial Infarction

Por Shiffman, Dov, Ellis, Stephen G., Rowland, Charles M., Malloy, Mary J., Luke, May M., Iakoubova, Olga A., Pullinger, Clive R., Cassano, June, Aouizerat, Bradley E., Fenwick, Raymond G., Reitz, Richard E., Catanese, Joseph J., Leong, Diane U., Zellner, Christian, Sninsky, John J., Topol, Eric J., Devlin, James J., Kane, John P.
Publicado em 2005

Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy

Por Shiffman, Dov, Trompet, Stella, Louie, Judy Z., Rowland, Charles M., Catanese, Joseph J., Iakoubova, Olga A., Kirchgessner, Todd G., Westendorp, Rudi G. J., de Craen, Anton J. M., Slagboom, P. Eline, Buckley, Brendan M., Stott, David J., Sattar, Naveed, Devlin, James J., Packard, Christopher J., Ford, Ian, Sacks, Frank M., Jukema, J. Wouter
Publicado em 2012